| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |